The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Huangshan Novel Co Ltd
SZSE:002014
|
CN |
|
Nicola Mining Inc
XTSX:NIM
|
CA |
|
Great Northern Minerals Ltd
OTC:GNMRF
|
AU |
|
S
|
Stora Enso Oyj
XETRA:ENUR
|
FI |
|
A
|
Alibaba Health Information Technology Ltd
F:TWY
|
HK |
|
Tenaris SA
MIL:TEN
|
LU |
|
Great Northern Minerals Ltd
F:3GW
|
AU |
|
Primerica Inc
NYSE:PRI
|
US |
|
A
|
Autoliv Inc
DUS:LIV
|
SE |
|
NHPC Ltd
BSE:533098
|
IN |
|
China Everbright Ltd
OTC:CEVIF
|
HK |
|
CACI International Inc
NYSE:CACI
|
US |
|
DKSH Holding AG
LSE:0QQE
|
CH |
|
R
|
Rasan Information Technology Company SCJSC
SAU:8313
|
SA |
|
E
|
Eurofins Scientific SE
DUS:ESF0
|
LU |
|
Infratil Ltd
OTC:IFUUF
|
NZ |
|
Astellas Pharma Inc
F:YPHA
|
JP |
|
ArcelorMittal SA
AEX:MT
|
LU |
|
P
|
Planktos Corp
OTC:PLKT
|
US |
Huangshan Novel Co Ltd (002014)’s 12-month stock price forecast through November 2027 has a consensus target of ¥14.25, implying 22% upside. The forecast is based on price targets from 3 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for Huangshan Novel Co Ltd is 14.25 CNY with a low forecast of 14.11 CNY and a high forecast of 14.67 CNY.
Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 3 years is 11%.
Over the last 13 years, the compound annual growth rate for Gross Profit has been 7%. The projected CAGR for the next 3 years is 10%.
Over the last 13 years, the compound annual growth rate for Operating Income has been 8%. The projected CAGR for the next 3 years is 9%.
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 7%. The projected CAGR for the next 3 years is 10%.
Over the last 13 years, the compound annual growth rate for Net Income has been 7%. The projected CAGR for the next 3 years is 10%.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Already have an account? Sign in
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more